This HTML5 document contains 188 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n18	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
n17	http://linked.opendata.cz/resource/sukl/specialization-restriction/
skos	http://www.w3.org/2004/02/skos/core#
n8	http://linked.opendata.cz/resource/sukl/indgroup/
n6	http://linked.opendata.cz/resource/sukl/packing/
n9	http://linked.opendata.cz/resource/sukl/company/
n19	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0155939/price-of-originator/
n14	http://linked.opendata.cz/resource/sukl/active-ingredient/
n13	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0155939/reimbursement/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n11	http://linked.opendata.cz/resource/sukl/registration-state/
n15	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0155939/
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0155939/core-reimbursement/
xsdh	http://www.w3.org/2001/XMLSchema#
n10	http://www.sukl.cz/modules/medication/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0155939/price/
n12	http://linked.opendata.cz/resource/sukl/df/
n7	http://linked.opendata.cz/resource/atc/

Statements

Subject Item

n2:0155939

rdf:type

n3:MedicinalProductPackaging

dcterms:title

HERPESIN 250

skos:notation

0155939

n3:hasATCCode

n7:J05AB01

n3:hasActiveIngredient

n14:ACICLOVIRUM-NATRICUM

n3:hasDefinedDailyDose

n15:ddd

n3:hasDosageForm

n12:PLV-SOL-INF

n3:hasPackagingSize

10

n3:hasPacking

n6:VIA

n3:hasRegistrationHolder

n9:TPPCZ

n3:hasRegistrationState

n11:R

n3:hasRouteOfAdministration

n18:INF

n3:hasStrength

250MG/LAH

n3:hasIndicationGroup

n8:42

n3:hasSpecializationRestriction

n17:ATB

n3:containsDefinedDailyDoses

0.625

n3:hasRegistrationCode

42/ 219/89-C

n3:hasTitleSupplement

INF PLV SOL 10X250MG

n3:containsUsualTherapeuticalDailyDoses

1.1111 0.625

n3:hasCoreReimbursementSpecification

n5:2015-04-01 n5:2015-04-02 n5:2015-02-01 n5:2015-03-01 n5:2015-07-01 n5:2015-07-02 n5:2015-05-01 n5:2015-06-01 n5:2013-02-01 n5:2013-03-01 n5:2013-01-01 n5:2013-01-05 n5:2013-06-01 n5:2013-07-01 n5:2013-04-01 n5:2013-05-01 n5:2013-09-01 n5:2013-10-01 n5:2013-08-01 n5:2013-08-03 n5:2014-01-01 n5:2014-02-01 n5:2013-11-01 n5:2013-12-01 n5:2014-05-01 n5:2014-06-01 n5:2014-03-01 n5:2014-04-01 n5:2014-07-03 n5:2014-08-01 n5:2014-06-13 n5:2014-07-01 n5:2014-10-02 n5:2014-11-01 n5:2014-09-01 n5:2014-10-01 n5:2015-01-01 n5:2015-01-13 n5:2014-11-19 n5:2014-12-01

n3:hasPriceOfOriginatorSpecification

n19:2014-07-03 n19:2015-07-01 n19:2014-08-01 n19:2015-07-02 n19:2014-06-13 n19:2015-05-01 n19:2014-07-01 n19:2015-06-01 n19:2014-05-01 n19:2015-04-01 n19:2014-06-01 n19:2015-04-02 n19:2014-03-01 n19:2015-02-01 n19:2014-04-01 n19:2015-03-01 n19:2014-01-01 n19:2015-01-01 n19:2014-02-01 n19:2015-01-13 n19:2013-11-01 n19:2014-11-19 n19:2013-12-01 n19:2014-12-01 n19:2013-09-01 n19:2014-10-02 n19:2013-10-01 n19:2014-11-01 n19:2013-08-01 n19:2014-09-01 n19:2013-08-03 n19:2014-10-01 n19:2013-06-01 n19:2013-07-01 n19:2013-04-01 n19:2013-05-01 n19:2013-02-01 n19:2013-03-01 n19:2013-01-01 n19:2013-01-05

n3:hasPriceSpecification

n4:2015-07-02 n4:2014-09-01 n4:2014-10-01 n4:2014-10-02 n4:2014-11-01 n4:2014-11-19 n4:2014-12-01 n4:2015-01-01 n4:2015-01-13 n4:2014-03-01 n4:2014-04-01 n4:2014-05-01 n4:2014-06-01 n4:2014-06-13 n4:2014-07-01 n4:2014-07-03 n4:2014-08-01 n4:2013-08-01 n4:2013-08-03 n4:2013-09-01 n4:2013-10-01 n4:2013-11-01 n4:2013-12-01 n4:2014-01-01 n4:2014-02-01 n4:2013-01-01 n4:2013-01-05 n4:2013-02-01 n4:2013-03-01 n4:2013-04-01 n4:2013-05-01 n4:2013-06-01 n4:2013-07-01 n4:2015-02-01 n4:2015-03-01 n4:2015-04-01 n4:2015-04-02 n4:2015-05-01 n4:2015-06-01 n4:2015-07-01

n3:hasReimbursementSpecification

n13:2015-04-01 n13:2015-04-02 n13:2015-02-01 n13:2015-03-01 n13:2015-07-01 n13:2015-07-02 n13:2015-05-01 n13:2015-06-01 n13:2014-10-02 n13:2014-11-01 n13:2014-09-01 n13:2014-10-01 n13:2015-01-01 n13:2015-01-13 n13:2014-11-19 n13:2014-12-01 n13:2014-05-01 n13:2014-06-01 n13:2014-03-01 n13:2014-04-01 n13:2014-07-03 n13:2014-08-01 n13:2014-06-13 n13:2014-07-01 n13:2013-09-01 n13:2013-10-01 n13:2013-08-01 n13:2013-08-03 n13:2014-01-01 n13:2014-02-01 n13:2013-11-01 n13:2013-12-01 n13:2013-02-01 n13:2013-03-01 n13:2013-01-01 n13:2013-01-05 n13:2013-06-01 n13:2013-07-01 n13:2013-04-01 n13:2013-05-01

n3:hasResumedMarketingDate

2010-08-16+02:00

n3:hasUsualTherapeuticalDailyDose

n15:utdd

n3:pilFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DPI53462.pdf%26type%3Dpil%26as%3Dherpesin-250-pil

n3:pilUri

n10:download.php?file=PI53462.pdf&type=pil&as=herpesin-250-pil

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC53463.pdf%26type%3Dspc%26as%3Dherpesin-250-spc

n3:spcUri

n10:download.php?file=SPC53463.pdf&type=spc&as=herpesin-250-spc

n3:textOnTheWrapFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DOBAL39812.pdf%26type%3Dobal%26as%3Dherpesin-250-obal

n3:textOnTheWrapUri

n10:download.php?file=OBAL39812.pdf&type=obal&as=herpesin-250-obal